Finetive 10Mg & 20Mg 10 mg, 20 mg FC TABLETS
PDF Leaflet Revision Date: 18 March 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of chronic kidney disease stage 3 and 4 with albuminuria associated with type 2 diabetes in adults.
Dosage (summary)
20 mg once daily; starting dose based on eGFR.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy; avoid breastfeeding.
Key Drug Interactions
- Strong CYP3A4 inhibitors
- Potassium-sparing diuretics
- Trimethoprim
Contraindications
- Hypersensitivity
- Severe hepatic impairment
- eGFR < 25 mL/min
Common side effects
- Hyperkalaemia
- Hypotension
- Pruritus
Counselling Points
- Take with water; avoid grapefruit juice.
- Monitor potassium levels regularly.
- Use effective contraception during treatment.
Serious warnings
- Risk of hyperkalaemia
- Monitoring of serum potassium required
On This Page
Loading package insert…
Medinsert AI
Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?
